Detalhe da pesquisa
1.
Indicators of Clinical Trajectory in Patients With Cancer Who Receive Cardiopulmonary Resuscitation.
J Natl Compr Canc Netw
; 21(1): 51-59.e10, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36634611
2.
Critically Ill Patients Treated for Chimeric Antigen Receptor-Related Toxicity: A Multicenter Study.
Crit Care Med
; 50(1): 81-92, 2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34259446
3.
Tocilizumab therapy in 5 solid and composite tissue transplant recipients with early ARDS due to SARS-CoV-2.
Am J Transplant
; 20(11): 3191-3197, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32476261
4.
Characteristics and Outcomes of Ethics Consultations in an Oncologic Intensive Care Unit.
J Intensive Care Med
; 30(7): 436-42, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24916755
5.
Management and Prevention of Cellular-Therapy-Related Toxicity: Early and Late Complications.
Curr Oncol
; 30(5): 5003-5023, 2023 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37232836
6.
Risk factors associated with development of coinfection in critically Ill patients with COVID-19.
Acute Crit Care
; 37(3): 312-321, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36102003
7.
Toxicities Associated with Immunotherapy and Approach to Cardiotoxicity with Novel Cancer Therapies.
Crit Care Clin
; 37(1): 47-67, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33190775
8.
A High Neutrophil-Lymphocyte Ratio Is Associated With Increased Morbidity and Mortality in Patients With Coronavirus Disease 2019.
Crit Care Explor
; 3(5): e0444, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-34036280
9.
Tocilizumab in Coronavirus Disease 2019-Related Critical Illness: A Propensity Matched Analysis.
Crit Care Explor
; 3(1): e0327, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33490955
10.
Critically ill patients with severe immune checkpoint inhibitor related neurotoxicity: A multi-center case series.
J Crit Care
; 65: 126-132, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34139658
11.
Surge capacity and capability of intensive care units across a large healthcare system: An operational blueprint for regional integration.
Am J Disaster Med
; 16(3): 179-192, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34904702
12.
Mavrilimumab in patients with severe COVID-19 pneumonia and systemic hyperinflammation (MASH-COVID): an investigator initiated, multicentre, double-blind, randomised, placebo-controlled trial.
Lancet Rheumatol
; 3(6): e410-e418, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33754144
13.
Double-blind randomized proof-of-concept trial of canakinumab in patients with COVID-19 associated cardiac injury and heightened inflammation.
Eur Heart J Open
; 1(1): oeab002, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35923169
14.
Ethical considerations during the COVID-19 pandemic.
Cleve Clin J Med
; 2020 Jun 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32493737
15.
Addressing caregiver moral distress during the COVID-19 pandemic.
Cleve Clin J Med
; 2020 Jun 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32518134
16.
Practical aspects of targeting IL-6 in COVID-19 disease.
Cleve Clin J Med
; 2020 Oct 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32409439
17.
Targeting GM-CSF in COVID-19 Pneumonia: Rationale and Strategies.
Front Immunol
; 11: 1625, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32719685
18.
Canakinumab to reduce deterioration of cardiac and respiratory function in SARS-CoV-2 associated myocardial injury with heightened inflammation (canakinumab in Covid-19 cardiac injury: The three C study).
Clin Cardiol
; 43(10): 1055-1063, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32830894
19.
The chimeric antigen receptor-intensive care unit (CAR-ICU) initiative: Surveying intensive care unit practices in the management of CAR T-cell associated toxicities.
J Crit Care
; 58: 58-64, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32361219
20.
Prescribing patterns for corticosteroids in septic shock: translating guidelines to bedside practice.
Crit Care Med
; 41(10): 2441-3, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24060775